Close
Google's DeepMind has announced that an AI-developed drug will enter clinical trials by the end of the year. This initiative aims to revolutionize the drug development process, which is often lengthy and expensive. The project is a significant step forward in leveraging artificial intelligence to enhance pharmaceutical research and development.
The AI-driven approach promises to streamline the drug discovery process, potentially reducing costs and timeframes significantly. With major pharmaceutical companies showing interest, the collaboration could lead to breakthroughs in treating various diseases. This development highlights the growing intersection of AI technology and healthcare innovation.
• AI-developed drug trials expected to start by year-end.
• Collaboration with pharmaceutical companies aims to reduce drug development costs.
Artificial intelligence refers to the simulation of human intelligence in machines, enabling them to perform tasks that typically require human cognition.
Drug development is the process of bringing a new pharmaceutical drug to the market, involving research, testing, and regulatory approval.
Clinical trials are research studies conducted with human participants to evaluate the efficacy and safety of new drugs or treatments.
Google is a leading technology company known for its advancements in artificial intelligence and machine learning applications, particularly in healthcare.
Alphabet is the parent company of Google, overseeing various subsidiaries, including those focused on AI research and development.
The Wall Street Journal 4month
Pharmaceutical Technology on MSN.com 9month
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.
Log in
Sign Up
AI Tools - Popular
AI Tools - Categories
GPTs - Categories
AI for Jobs
Key AI Highlights in this Article
Key AI Terms Mentioned in this Article
Companies Mentioned in this Article
